Sean T. Kelleher
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Sean T. Kelleher has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Colin Joseph McMahon
Department of Paediatric Cardiology, Children’s Health Ireland at Crumlin, Crumlin, Ireland
5 shared publications - Adam James
Department of Paediatric Cardiology, Children’s Health Ireland at Crumlin, Crumlin, Ireland
3 shared publications - Agnes Higgins
School of Nursing and Midwifery, Trinity College Dublin, Dublin
3 shared publications - Dani Hall
Department of Emergency Medicine Children's Health Ireland at Crumlin Dublin Ireland
3 shared publications - Irene E. Regan
Department of Coagulation/Haematology, Children’s Health Ireland at Crumlin, Dublin, Ireland
2 shared publications Kevin P. Walsh
Department of Pediatric Cardiology, Children’s Health Ireland at Crumlin, Dublin, Ireland
2 shared publications
Latest Publications
Gut-brain-heart axis in congenital heart disease: emerging roles of the microbiome in cardiac physiology and neurodevelopment
Congenital heart disease (CHD) is increasingly recognised as a multisystem condition extending beyond structural cardiac abnormalities to include gastrointestinal, immunological and neurodevelopmental consequences. Although advances in surgical and intensive care have significantly improved survival, children with CHD remain at heightened risk for adverse neurodevelopmental outcomes, systemic inflammation and gastrointestinal morbidity. The gut microbiome plays a central role in immune regulation, metabolic homeostasis and brain development particularly during early life. Perturbations of the microbiome are common in infants with CHD due to altered gut perfusion, antibiotic exposure, feeding disruption and cardiopulmonary bypass (CPB). These changes may influence both cardiac recovery and neurodevelopment through interconnected gut-heart-brain signalling pathways. This review synthesises current evidence linking the gut microbiome to cardiac physiology and brain development in children with CHD, with particular emphasis on early-life vulnerability, perioperative factors and emerging translational insights. Understanding these interactions may inform future strategies to optimise long-term outcomes in this high-risk population.
Gut-brain-heart axis in congenital heart disease: emerging roles of the microbiome in cardiac physiology and neurodevelopment
Congenital heart disease (CHD) is increasingly recognised as a multisystem condition extending beyond structural cardiac abnormalities to include gastrointestinal, immunological and neurodevelopmental consequences. Although advances in surgical and intensive care have significantly improved survival, children with CHD remain at heightened risk for adverse neurodevelopmental outcomes, systemic inflammation and gastrointestinal morbidity. The gut microbiome plays a central role in immune regulation, metabolic homeostasis and brain development particularly during early life. Perturbations of the microbiome are common in infants with CHD due to altered gut perfusion, antibiotic exposure, feeding disruption and cardiopulmonary bypass (CPB). These changes may influence both cardiac recovery and neurodevelopment through interconnected gut-heart-brain signalling pathways. This review synthesises current evidence linking the gut microbiome to cardiac physiology and brain development in children with CHD, with particular emphasis on early-life vulnerability, perioperative factors and emerging translational insights. Understanding these interactions may inform future strategies to optimise long-term outcomes in this high-risk population.
- Open Access
- 5 August 2026
- Published by BMJ in Archives of Disease in Childhood
- Vol. 111 (12) , 1033-1040
International healthcare professionals competence in caring for LGBTQ+ children and young people: a combined qualitative and quantitative approach
Objective To evaluate healthcare professionals’ attitudes, knowledge and clinical preparedness in caring for lesbian, gay, bisexual, transgender, queer/questioning; the + denoting inclusion of all identities (LGBTQ+) children and young people across international healthcare settings. Design Mixed-methods study incorporating quantitative self-assessment of clinical competency using the LGBT-Development of Clinical Skills Scale (LGBT-DOCSS) and qualitative free-text responses exploring educational needs and perceived barriers to providing inclusive care, hosted on the Don’t Forget The Bubbles platform. Participants 771 healthcare professionals; 770 included after removal of one duplicate. Main outcome measures Self-reported attitudes, knowledge and clinical preparedness using LGBT-DOCSS composite scores and qualitative coding of free-text responses examining contextual drivers of clinicians’ confidence and practice. Results Respondents were largely experienced clinicians (66% with ≥10 years in healthcare). Mean total LGBT-DOCSS Score was 5.42/7 (SD 0.80). Attitudinal scores were high (mean 6.54, SD 0.88), while basic knowledge (5.40, SD 1.26) and clinical preparedness in particular (4.31, SD 1.29) were lower. Education-related preparedness items scored the lowest, particularly regarding transgender and gender-diverse care (2.92, SD 1.69). Qualitative analysis identified two themes: barriers to inclusive care, which encompassed structural constraints, cultural norms and emotional or psychological barriers; and desire for competence, which encompassed recognition of knowledge gaps, need for transgender-specific training and desire for practical, lived-experience-informed education. Conclusions Healthcare professionals report positive attitudes but limited knowledge and preparedness. Clinicians are motivated to provide inclusive care but system-level support, structured education and skills-based training are required to translate intent into competent, inclusive clinical practice.
- 5 August 2026
- Published by BMJ in Archives of Disease in Childhood
- Vol. 111 (12) , 1033-1040
Open AccessInternational healthcare professionals competence in caring for LGBTQ+ children and young people: a combined qualitative and quantitative approach
Objective To evaluate healthcare professionals’ attitudes, knowledge and clinical preparedness in caring for lesbian, gay, bisexual, transgender, queer/questioning; the + denoting inclusion of all identities (LGBTQ+) children and young people across international healthcare settings. Design Mixed-methods study incorporating quantitative self-assessment of clinical competency using the LGBT-Development of Clinical Skills Scale (LGBT-DOCSS) and qualitative free-text responses exploring educational needs and perceived barriers to providing inclusive care, hosted on the Don’t Forget The Bubbles platform. Participants 771 healthcare professionals; 770 included after removal of one duplicate. Main outcome measures Self-reported attitudes, knowledge and clinical preparedness using LGBT-DOCSS composite scores and qualitative coding of free-text responses examining contextual drivers of clinicians’ confidence and practice. Results Respondents were largely experienced clinicians (66% with ≥10 years in healthcare). Mean total LGBT-DOCSS Score was 5.42/7 (SD 0.80). Attitudinal scores were high (mean 6.54, SD 0.88), while basic knowledge (5.40, SD 1.26) and clinical preparedness in particular (4.31, SD 1.29) were lower. Education-related preparedness items scored the lowest, particularly regarding transgender and gender-diverse care (2.92, SD 1.69). Qualitative analysis identified two themes: barriers to inclusive care, which encompassed structural constraints, cultural norms and emotional or psychological barriers; and desire for competence, which encompassed recognition of knowledge gaps, need for transgender-specific training and desire for practical, lived-experience-informed education. Conclusions Healthcare professionals report positive attitudes but limited knowledge and preparedness. Clinicians are motivated to provide inclusive care but system-level support, structured education and skills-based training are required to translate intent into competent, inclusive clinical practice.
- 9 June 2025
- Published by BMJ in Archives of Disease in Childhood - Education & Practice Edition
- Vol. 111 (1) , 34-35
Tale of two blood gases
- 9 June 2025
- Published by BMJ in Archives of Disease in Childhood - Education & Practice Edition
- Vol. 111 (1) , 34-35
Tale of two blood gases
- Open Access
- 30 January 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (1) , 2401445
Up-regulated matrix metalloproteinase activity in soil-transmitted helminth–tuberculosis co-infection is associated with increased lung pathology
Tuberculosis (TB) and soil-transmitted helminths (STHs) are major global health concerns, affecting approximately 1.5 billion and 1.8 billion people, respectively [1, 2]. Both are prevalent in poverty-stricken areas, and helminth infections are thought to polarise the immune response towards a type 2 response, possibly increasing susceptibility to TB [3, 4]. A major concern with TB is lung tissue destruction, which leads to high mortality and long-term morbidity [5]. In 2019, new active TB cases resulted in approximately 122 million disability-adjusted life years, with a projected economic cost of nearly USD 1 trillion from TB deaths between 2015 and 2030 [6, 7]. Individuals co-infected with TB and helminths may experience more severe lung damage compared to those with TB alone [8, 9].
- 30 January 2025
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 65 (1) , 2401445
Open AccessUp-regulated matrix metalloproteinase activity in soil-transmitted helminth–tuberculosis co-infection is associated with increased lung pathology
Tuberculosis (TB) and soil-transmitted helminths (STHs) are major global health concerns, affecting approximately 1.5 billion and 1.8 billion people, respectively [1, 2]. Both are prevalent in poverty-stricken areas, and helminth infections are thought to polarise the immune response towards a type 2 response, possibly increasing susceptibility to TB [3, 4]. A major concern with TB is lung tissue destruction, which leads to high mortality and long-term morbidity [5]. In 2019, new active TB cases resulted in approximately 122 million disability-adjusted life years, with a projected economic cost of nearly USD 1 trillion from TB deaths between 2015 and 2030 [6, 7]. Individuals co-infected with TB and helminths may experience more severe lung damage compared to those with TB alone [8, 9].
- Open Access
- 1 August 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (8) , 1714-1722
Efficacy and speed of effect after the first dose of aspirin in children with congenital heart disease
Background: Many paediatric studies report that patients must be established on aspirin therapy for a minimum of 5 days to achieve adequate response. This is not always practical especially in critical settings. Prospective identification of patients that are unresponsive to aspirin sooner could potentially prevent thrombotic events.Aims: The aim of this study was to investigate prospectively if the first dose of aspirin is effective in decreasing platelet aggregation, and thromboxane formation and if this can be measured after 2 hours in paediatric cardiology patients. A secondary aim was to identify a cut-off for a novel marker of aspirin responsiveness the maximum amplitude with arachidonic acid, which could potentially dramatically reduce the blood volume required. Third, we aimed to prospectively identify potentially non-responsive patients by spiking a sample of their blood ex vivo with aspirin.Results: The majority (92.3%) of patients were responsive, when measured 2 hours post first dose of aspirin. Non-response or inadequate response (7.7%) can also be identified at 2 hours after taking the first dose of aspirin. Additionally, we have shown a novel way to reduce blood sample volume requirements by measurement of the maximum amplitude with arachidonic acid as a marker of response, particularly for monitoring.Conclusions: These findings of rapid efficacy in the majority of patients offer assurance in a sound, practical way to attending clinicians, patients, and families.
- 1 August 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (8) , 1714-1722
Open AccessEfficacy and speed of effect after the first dose of aspirin in children with congenital heart disease
Background: Many paediatric studies report that patients must be established on aspirin therapy for a minimum of 5 days to achieve adequate response. This is not always practical especially in critical settings. Prospective identification of patients that are unresponsive to aspirin sooner could potentially prevent thrombotic events.Aims: The aim of this study was to investigate prospectively if the first dose of aspirin is effective in decreasing platelet aggregation, and thromboxane formation and if this can be measured after 2 hours in paediatric cardiology patients. A secondary aim was to identify a cut-off for a novel marker of aspirin responsiveness the maximum amplitude with arachidonic acid, which could potentially dramatically reduce the blood volume required. Third, we aimed to prospectively identify potentially non-responsive patients by spiking a sample of their blood ex vivo with aspirin.Results: The majority (92.3%) of patients were responsive, when measured 2 hours post first dose of aspirin. Non-response or inadequate response (7.7%) can also be identified at 2 hours after taking the first dose of aspirin. Additionally, we have shown a novel way to reduce blood sample volume requirements by measurement of the maximum amplitude with arachidonic acid as a marker of response, particularly for monitoring.Conclusions: These findings of rapid efficacy in the majority of patients offer assurance in a sound, practical way to attending clinicians, patients, and families.
- Open Access
- 22 April 2024
- Published by Elsevier in JACC: Case Reports
- Vol. 29 (12) , 102340
Novel Staged Device Occlusion of Portosystemic Shunt With Atrial Flow Regulator in IVC Stent Platform
- 22 April 2024
- Published by Elsevier in JACC: Case Reports
- Vol. 29 (12) , 102340
Open AccessNovel Staged Device Occlusion of Portosystemic Shunt With Atrial Flow Regulator in IVC Stent Platform
- Open Access
- 2 April 2024
- Published by Springer Nature in Pediatric Cardiology
- Vol. 46 (3) , 580-589
Twinning International Pediatric Cardiology Fellowship Programs: A Transformative Educational Experience for Trainees with Potential for Global Adoption
Over the last decade, having endured the COVID-19 pandemic, education and training in pediatric cardiology have undergone a profound disruptive transformation. Trainees experience considerable stress achieving all the competencies required to become a competent pediatric cardiologist. Often the quality of the training experienced by trainees, the approach to patients, and potential institutional preference in management strategy is heavily influenced by the center in which they train. We developed an online live twin program of education between Texas Children’s Hospital, Houston, Texas and Children’s Health at Crumlin Dublin Ireland in 2019. We explored using grounded theory whether a regular scheduled shared teaching program improved fellow education and training between both centers. Trainees were surveyed to evaluate the benefits and disadvantages of such a twin program. The majority (93%) found the sessions helpful from an educational standpoint with many trainees reporting it to be a transformative experience. Three important learning themes emerged: practice variation between centers, managing uncertainty in clinical practice and cognitive overload. This pedagogical model could be replicated across multiple international pediatric cardiology units and facilitate “collaborative learning” among centers across the globe. Furthermore, this novel educational model could also be adopted by other medical specialties.
- 2 April 2024
- Published by Springer Nature in Pediatric Cardiology
- Vol. 46 (3) , 580-589
Open AccessTwinning International Pediatric Cardiology Fellowship Programs: A Transformative Educational Experience for Trainees with Potential for Global Adoption
Over the last decade, having endured the COVID-19 pandemic, education and training in pediatric cardiology have undergone a profound disruptive transformation. Trainees experience considerable stress achieving all the competencies required to become a competent pediatric cardiologist. Often the quality of the training experienced by trainees, the approach to patients, and potential institutional preference in management strategy is heavily influenced by the center in which they train. We developed an online live twin program of education between Texas Children’s Hospital, Houston, Texas and Children’s Health at Crumlin Dublin Ireland in 2019. We explored using grounded theory whether a regular scheduled shared teaching program improved fellow education and training between both centers. Trainees were surveyed to evaluate the benefits and disadvantages of such a twin program. The majority (93%) found the sessions helpful from an educational standpoint with many trainees reporting it to be a transformative experience. Three important learning themes emerged: practice variation between centers, managing uncertainty in clinical practice and cognitive overload. This pedagogical model could be replicated across multiple international pediatric cardiology units and facilitate “collaborative learning” among centers across the globe. Furthermore, this novel educational model could also be adopted by other medical specialties.
- Open Access
- 15 March 2024
- Published by Springer Nature in Pediatric Cardiology
- Vol. 46 (2) , 485-493
Aspirin Responsiveness in a Cohort of Pediatric Patients with Right Ventricle to Pulmonary Artery Conduits and Transcatheter Valve Replacement Systems
The aim of this study was to determine the rate of aspirin responsiveness in a cohort of pediatric patients with in situ xenograft valved right ventricle to pulmonary artery (RV-PA) conduits and/or transcatheter valve replacements (TVR). Aspirin is routinely prescribed to these patients. Optimizing anti-platelet therapy could promote valve longevity and reduce the risk of infective endocarditis in this at-risk group. This was a prospective, observational study. Patients were recruited from both ward and outpatient settings. Patients were eligible if under 18 years and taking aspirin. Non-response to aspirin was defined as > 20% platelet aggregation using light transmission platelet aggregometry (LTA) and < 50% platelet inhibition by thromboelastography with platelet mapping (TEGPM). Participants were invited to provide a confirmatory sample in cases of aspirin resistance and dose adjustments were made. Thirty patients participated. Median age was 9 years (2 months to 18 years). The majority (93%) had complex right ventricular outflow tract pathology. 13 (43%) had an RV-PA conduit and 24 (80%) had a TVR, with valve situated in conduit in 7 (23%) cases. Rate of aspirin non-response on initial testing was 23% (n = 7/30) with median LTA 74.55% (60–76%) and TEG 13.25% (0–44%) in non-responders. Non-responders were more likely to be under 1 year. Two patients required dose increases and one patient non-adherence to dose was identified. Four patients on repeat testing were responsive to aspirin by laboratory tests. The rate of aspirin non-response on laboratory testing in this cohort of patients was 23% and resulted in therapeutic intervention in 10%.
- 15 March 2024
- Published by Springer Nature in Pediatric Cardiology
- Vol. 46 (2) , 485-493
Open AccessAspirin Responsiveness in a Cohort of Pediatric Patients with Right Ventricle to Pulmonary Artery Conduits and Transcatheter Valve Replacement Systems
The aim of this study was to determine the rate of aspirin responsiveness in a cohort of pediatric patients with in situ xenograft valved right ventricle to pulmonary artery (RV-PA) conduits and/or transcatheter valve replacements (TVR). Aspirin is routinely prescribed to these patients. Optimizing anti-platelet therapy could promote valve longevity and reduce the risk of infective endocarditis in this at-risk group. This was a prospective, observational study. Patients were recruited from both ward and outpatient settings. Patients were eligible if under 18 years and taking aspirin. Non-response to aspirin was defined as > 20% platelet aggregation using light transmission platelet aggregometry (LTA) and < 50% platelet inhibition by thromboelastography with platelet mapping (TEGPM). Participants were invited to provide a confirmatory sample in cases of aspirin resistance and dose adjustments were made. Thirty patients participated. Median age was 9 years (2 months to 18 years). The majority (93%) had complex right ventricular outflow tract pathology. 13 (43%) had an RV-PA conduit and 24 (80%) had a TVR, with valve situated in conduit in 7 (23%) cases. Rate of aspirin non-response on initial testing was 23% (n = 7/30) with median LTA 74.55% (60–76%) and TEG 13.25% (0–44%) in non-responders. Non-responders were more likely to be under 1 year. Two patients required dose increases and one patient non-adherence to dose was identified. Four patients on repeat testing were responsive to aspirin by laboratory tests. The rate of aspirin non-response on laboratory testing in this cohort of patients was 23% and resulted in therapeutic intervention in 10%.
- Open Access
- 2 January 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (6) , 1232-1238
Outcomes and characteristics in term infants with necrotising enterocolitis and CHD
Background: CHD is a significant risk factor for the development of necrotising enterocolitis. Existing literature does not differentiate between term and preterm populations. Long-term outcomes of these patients are not well understood. The aim was to investigate the baseline characteristics and outcomes of term normal birth weight infants with CHD who developed necrotising enterocolitis.Methods: A retrospective review was performed of infants from a single tertiary centre with CHD who developed necrotising enterocolitis of Bell’s Stage 1–3, over a ten-year period. Inclusion criteria was those born greater than 36 weeks’ gestation and birth weight over 2500g. Exclusion criteria included congenital gastro-intestinal abnormalities. Sub-group analysis was performed using Fisher’s exact test.Results: Twenty-five patients were identified, with a median gestational age of 38 weeks. Patients with univentricular physiology accounted for 32% (n = 8) and 52% of patients (n = 13) had a duct-dependent lesion. Atrioventricular septal defect was the most common cardiac diagnosis (n = 6, 24%). Patients with trisomy 21 accounted for 20% of cases. Mortality within 30 days of necrotising enterocolitis was 20%. Long-term mortality was 40%, which increased with increasing Bell’s Stage. In total, 36% (n = 9) required surgical management of necrotising enterocolitis, the rate of which was significantly higher in trisomy 21 cases (p < 0.05).Conclusion: Not previously described in term infants is the high rate of trisomy 21 and atrioventricular septal defect. This may reflect higher baseline incidence in our population. Infants with trisomy 21 were more likely to develop surgical necrotising enterocolitis. Mortality at long-term follow-up was high in patients with Bell’s Stage 2–3.
- 2 January 2024
- Published by Cambridge University Press (CUP) in Cardiology in the Young
- Vol. 34 (6) , 1232-1238
Open AccessOutcomes and characteristics in term infants with necrotising enterocolitis and CHD
Background: CHD is a significant risk factor for the development of necrotising enterocolitis. Existing literature does not differentiate between term and preterm populations. Long-term outcomes of these patients are not well understood. The aim was to investigate the baseline characteristics and outcomes of term normal birth weight infants with CHD who developed necrotising enterocolitis.Methods: A retrospective review was performed of infants from a single tertiary centre with CHD who developed necrotising enterocolitis of Bell’s Stage 1–3, over a ten-year period. Inclusion criteria was those born greater than 36 weeks’ gestation and birth weight over 2500g. Exclusion criteria included congenital gastro-intestinal abnormalities. Sub-group analysis was performed using Fisher’s exact test.Results: Twenty-five patients were identified, with a median gestational age of 38 weeks. Patients with univentricular physiology accounted for 32% (n = 8) and 52% of patients (n = 13) had a duct-dependent lesion. Atrioventricular septal defect was the most common cardiac diagnosis (n = 6, 24%). Patients with trisomy 21 accounted for 20% of cases. Mortality within 30 days of necrotising enterocolitis was 20%. Long-term mortality was 40%, which increased with increasing Bell’s Stage. In total, 36% (n = 9) required surgical management of necrotising enterocolitis, the rate of which was significantly higher in trisomy 21 cases (p < 0.05).Conclusion: Not previously described in term infants is the high rate of trisomy 21 and atrioventricular septal defect. This may reflect higher baseline incidence in our population. Infants with trisomy 21 were more likely to develop surgical necrotising enterocolitis. Mortality at long-term follow-up was high in patients with Bell’s Stage 2–3.
- 20 October 2023
- Published by BMJ in Archives of Disease in Childhood
- Vol. 109 (2) , 173-174
Improving clinical competence with LGBTQ+ patients in the paediatric emergency department: an education intervention study
Using a pre-test post-test design, competence was assessed at baseline, 2 and 12 weeks post an educational intervention consisting of an existing eLearning module, video and blogpost. The study was conducted between May and September 2021 across four centres. Eligible participants were 71 doctors, …
- 20 October 2023
- Published by BMJ in Archives of Disease in Childhood
- Vol. 109 (2) , 173-174
Improving clinical competence with LGBTQ+ patients in the paediatric emergency department: an education intervention study
Using a pre-test post-test design, competence was assessed at baseline, 2 and 12 weeks post an educational intervention consisting of an existing eLearning module, video and blogpost. The study was conducted between May and September 2021 across four centres. Eligible participants were 71 doctors, …